Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00711113 · ClinicalTrials.gov registry record · NA

Study on OsseoSpeed™ Implants Replacing 2-5 Teeth in the Posterior Upper Jaw, Restored With Provisional Teeth Attached 6-7 Weeks Later

A NA study of Jaw, Edentulous, Partially, sponsored by Dentsply Sirona Implants and Consumables.

Completed
Registry status
NA
Development phase
47
Enrollment target
3
Study locations

NCT00711113 is a NA study of Jaw, Edentulous, Partially that has completed, run by Dentsply Sirona Implants and Consumables. The registered enrollment target is 47 participants, below the 127-participant average among 5 other Jaw, Edentulous, Partially trials with a reported enrollment target (63% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00711113, a NA study of Jaw, Edentulous, Partially, has completed, sponsored by Dentsply Sirona Implants and Consumables.

COMPLETED
Registry status
NA
Development phase
47 participants
Enrollment target
3
Study locations

Study Summary

The purpose of the study is to evaluate Astra Tech Dental Implant System, Fixture Osseospeed™, in patients with tooth loss in the posterior maxilla in an early loading protocol. Primary objectives are implant stability, marginal bone adaptation and survival rate.

Conditions Studied

Interventions

  • DEVICE OsseoSpeed™

Study Locations (3)

Iowa

  • University of Iowa, College of Dentistry, Dow's Institute for Dental Research - Iowa City

Texas

  • UTHSCSA - San Antonio

Other

  • Universitetsklinik Mainz, Klinik fur ZMK - Mainz

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2003-12
Phase NA

What the Registry Record Tells You About NCT00711113

The ClinicalTrials.gov registry entry for NCT00711113 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 127-participant average among 5 other Jaw, Edentulous, Partially trials with a reported enrollment target (63% lower). The listed sponsor is Dentsply Sirona Implants and Consumables, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Jaw, Edentulous, Partially appearing as the primary indexed condition, and to 1 intervention - of which OsseoSpeed™ is the first listed.

NCT00711113 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Iowa, Texas, Other.

Frequently Asked Questions

What is clinical trial NCT00711113 about?

NCT00711113 is a clinical study titled "Study on OsseoSpeed™ Implants Replacing 2-5 Teeth in the Posterior Upper Jaw, Restored With Provisional Teeth Attached 6-7 Weeks Later". The purpose of the study is to evaluate Astra Tech Dental Implant System, Fixture Osseospeed™, in patients with tooth loss in the posterior maxilla in an early loading protocol. Primary objectives are implant stability, marginal bone adaptation and survival rate.

What is the current status of trial NCT00711113?

This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2003-12.

What conditions does trial NCT00711113 study?

This clinical trial studies the following conditions: Jaw, Edentulous, Partially.

What interventions are being tested in trial NCT00711113?

The interventions under investigation include: OsseoSpeed™ (DEVICE).

Who is sponsoring clinical trial NCT00711113?

This trial is sponsored by Dentsply Sirona Implants and Consumables, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00711113 being conducted?

This trial has 3 study locations across Iowa, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Jaw, Edentulous, Partially

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.